Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
CRH
CRH
|
+$552M |
| 2 |
Shopify
SHOP
|
+$433M |
| 3 |
Intel
INTC
|
+$394M |
| 4 |
UBS Group
UBS
|
+$364M |
| 5 |
Advanced Micro Devices
AMD
|
+$334M |
Top Sells
| 1 |
Amazon
AMZN
|
+$564M |
| 2 |
Salesforce
CRM
|
+$525M |
| 3 |
Oracle
ORCL
|
+$455M |
| 4 |
EOG Resources
EOG
|
+$350M |
| 5 |
Meta Platforms (Facebook)
META
|
+$267M |
Sector Composition
| 1 | Technology | 28.69% |
| 2 | Financials | 12.18% |
| 3 | Healthcare | 11.69% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Ligand Pharmaceuticals
LGND
$3.23B
| $3.07M | ﹤0.01% |
43,037
+372
| +0.9% | +$26.6K |
|
2202
Varex Imaging
VREX
$465M
| $3.07M | ﹤0.01% |
149,891
-131
| -0.1% | -$2.69K |
|
|
VRN
2203
DELISTED
Veren
VRN
| $3.07M | ﹤0.01% |
+440,754
| New | +$3.07M |
|
2204
Shoe Carnival
SCVL
$633M
| $3.06M | ﹤0.01% |
101,337
+361
| +0.4% | +$10.9K |
|
2205
FuelCell Energy
FCEL
$199M
| $3.06M | ﹤0.01% |
63,773
+4,501
| +8% | +$216K |
|
2206
Dole
DOLE
$1.31B
| $3.05M | ﹤0.01% |
248,513
+63,361
| +34% | +$779K |
|
2207
Vera Therapeutics
VERA
$1.54B
| $3.05M | ﹤0.01% |
198,184
-92,714
| -32% | -$1.43M |
|
2208
VSE Corp
VSEC
$3.44B
| $3.04M | ﹤0.01% |
46,978
+8,383
| +22% | +$542K |
|
2209
Ameresco
AMRC
$1.42B
| $3.02M | ﹤0.01% |
95,465
+1,206
| +1% | +$38.2K |
|
2210
Mobileye
MBLY
$11.3B
| $3.02M | ﹤0.01% |
69,689
-1,468
| -2% | -$63.6K |
|
|
HIBB
2211
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $3.01M | ﹤0.01% |
41,829
+404
| +1% | +$29.1K |
|
2212
ChargePoint
CHPT
$236M
| $3.01M | ﹤0.01% |
64,353
+25,738
| +67% | +$1.2M |
|
2213
Keros Therapeutics
KROS
$634M
| $3.01M | ﹤0.01% |
75,596
+4,578
| +6% | +$182K |
|
|
KAMN
2214
DELISTED
Kaman Corp
KAMN
| $3M | ﹤0.01% |
125,192
+35,373
| +39% | +$847K |
|
2215
Phinia Inc
PHIN
$2.29B
| $2.99M | ﹤0.01% |
98,877
+3,030
| +3% | +$91.8K |
|
2216
Interface
TILE
$1.66B
| $2.97M | ﹤0.01% |
235,559
-1,869
| -0.8% | -$23.6K |
|
2217
Sana Biotechnology
SANA
$841M
| $2.97M | ﹤0.01% |
728,034
-43,405
| -6% | -$177K |
|
2218
Shenandoah Telecom
SHEN
$747M
| $2.95M | ﹤0.01% |
136,473
+3,447
| +3% | +$74.5K |
|
2219
Virgin Galactic
SPCE
$189M
| $2.95M | ﹤0.01% |
60,174
+27,109
| +82% | +$1.33M |
|
2220
Pitney Bowes
PBI
$1.96B
| $2.94M | ﹤0.01% |
668,445
+200,132
| +43% | +$881K |
|
2221
TriMas Corp
TRS
$1.59B
| $2.94M | ﹤0.01% |
115,985
+1,107
| +1% | +$28K |
|
2222
Caleres
CAL
$507M
| $2.93M | ﹤0.01% |
95,499
+1,978
| +2% | +$60.8K |
|
2223
Genesco
GCO
$350M
| $2.91M | ﹤0.01% |
82,520
-1,784
| -2% | -$62.8K |
|
2224
Cytek Biosciences
CTKB
$523M
| $2.9M | ﹤0.01% |
317,746
+8,436
| +3% | +$76.9K |
|
|
ETWO
2225
DELISTED
E2open Parent Holdings
ETWO
| $2.89M | ﹤0.01% |
658,976
-9,721
| -1% | -$42.7K |
|